Eliem Therapeutics | DEFA14A: Others
Apr 11 20:14
Eliem Therapeutics | 8-K: Current report
Apr 11 20:04
Eliem Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 29 04:35
Eliem Therapeutics | 8-K: Current report
Mar 20 01:33
Eliem Therapeutics | 8-K: Current report
Jul 20, 2023 18:55
Eliem Therapeutics | 8-K: Current report
May 20, 2023 04:45
Eliem Therapeutics | 8-K: Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
May 12, 2023 04:12
Eliem Therapeutics | DEFA14A: Others
Apr 7, 2023 04:10
Eliem Therapeutics | DEF 14A: Definitive proxy statements
Apr 7, 2023 04:05
Eliem Therapeutics | 8-K: Current report
Mar 17, 2023 04:30
Eliem Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 7, 2023 05:59
Eliem Therapeutics | 8-K: Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
Mar 7, 2023 05:52
Eliem Therapeutics | 8-K: Current report
Feb 14, 2023 10:09
Eliem Therapeutics | 8-K: Current report
Jan 25, 2023 05:21
Eliem Therapeutics | 8-K: Current report
Dec 21, 2022 05:02
Eliem Therapeutics | 8-K: Current report
Nov 14, 2022 19:10
Eliem Therapeutics | 8-K: Current report
Oct 5, 2022 19:47
Eliem Therapeutics | 8-K: Current report
Aug 15, 2022 18:15
Eliem Therapeutics | 8-K: Current report
Jul 19, 2022 05:21
Eliem Therapeutics | 8-K: Current report
May 25, 2022 04:13
No Data
No Data